X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (35) 35
hygiene (35) 35
medical or veterinary science (35) 35
preparations for medical, dental, or toilet purposes (35) 35
specific therapeutic activity of chemical compounds ormedicinal preparations (32) 32
immunogenicity (5) 5
index medicus (5) 5
adalimumab (4) 4
patients (4) 4
rheumatoid arthritis (4) 4
b cells (3) 3
biology and life sciences (3) 3
care and treatment (3) 3
consortia (3) 3
cytokines (3) 3
disease (3) 3
drug therapy (3) 3
humans (3) 3
immunology (3) 3
infliximab (3) 3
medicine (3) 3
medicine and health sciences (3) 3
multidisciplinary sciences (3) 3
research and analysis methods (3) 3
risk factors (3) 3
science (3) 3
adult (2) 2
animal cells (2) 2
anti-drug antibodies (2) 2
anti-tnf (2) 2
antibodies (2) 2
antibodies - immunology (2) 2
antigens (2) 2
arthritis (2) 2
autoimmune diseases (2) 2
biochemistry (2) 2
biopharmaceutics (2) 2
blood cells (2) 2
cell biology (2) 2
cellular types (2) 2
clinical medicine (2) 2
clinical trials (2) 2
dendritic cells (2) 2
dosage and administration (2) 2
drb1 protein (2) 2
drug dosages (2) 2
efficacy (2) 2
female (2) 2
histocompatibility antigen hla (2) 2
ifn-beta (2) 2
immune cells (2) 2
immune physiology (2) 2
immune response (2) 2
immune system proteins (2) 2
immunoglobulins (2) 2
male (2) 2
medical and health sciences (2) 2
medicin och hälsovetenskap (2) 2
middle aged (2) 2
physiology (2) 2
proteins (2) 2
regression analysis (2) 2
research article (2) 2
systematic review (2) 2
t cells (2) 2
t-cells (2) 2
therapy (2) 2
tumor necrosis factor-tnf (2) 2
white blood cells (2) 2
adenosine (1) 1
aged (1) 1
allergic reactions (1) 1
analysis (1) 1
anaphylaxis (1) 1
anti-tnf treatment (1) 1
antibodies - blood (1) 1
antibodies, anti-idiotypic - blood (1) 1
antibodies, anti-idiotypic - immunology (1) 1
antibodies/immunology (1) 1
antigen-presenting cells (1) 1
association (1) 1
austria (1) 1
autoimmunity (1) 1
b-cell (1) 1
backup software (1) 1
basal insulin (1) 1
basic medicine (1) 1
binding-antibodies (1) 1
biological response modifiers (1) 1
biomarkers (1) 1
blocking antibodies (1) 1
blood & organ donations (1) 1
blood coagulation factor viii (1) 1
blood glucose - drug effects (1) 1
blood-pressure (1) 1
blys protein (1) 1
braiding (1) 1
cd20 antigen (1) 1
cd4 antigen (1) 1
cd4-positive t-lymphocytes - immunology (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (35) 35
French (7) 7
Spanish (6) 6
Chinese (5) 5
German (3) 3
Portuguese (3) 3
Korean (2) 2
Croatian (1) 1
Danish (1) 1
Greek (1) 1
Hungarian (1) 1
Japanese (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Diabetes care, ISSN 0149-5992, 07/2015, Volume 38, Issue 7, pp. 1263 - 1273
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2019, Volume 14, Issue 6, p. e0218258
Journal Article
PLoS ONE, ISSN 1932-6203, 11/2016, Volume 11, Issue 11, p. e0162752
Immunogenicity of biopharmaceutical products in multiple sclerosis is a frequent side effect which has a multifactorial etiology. Here we study associations... 
IFN-BETA | VITAMIN-D | BINDING-ANTIBODIES | CONTROLLED-TRIAL | IMMUNOGENICITY | NEUTRALIZING ANTIBODIES | THERAPY | INTERVAL-CENSORED-DATA | AUTOIMMUNITY | MULTIDISCIPLINARY SCIENCES | T-CELLS | Interferon-beta - immunology | Humans | Middle Aged | Natalizumab - adverse effects | Natalizumab - immunology | Male | Multiple Sclerosis - epidemiology | Interferon-beta - therapeutic use | Interferon-beta - adverse effects | Natalizumab - therapeutic use | Antibodies - immunology | Adult | Female | Databases, Factual | Multiple Sclerosis - mortality | Antibodies, Anti-Idiotypic - blood | Risk Factors | Proportional Hazards Models | Antibodies, Anti-Idiotypic - immunology | Europe - epidemiology | Patient Outcome Assessment | Multiple Sclerosis - complications | Antibodies - blood | Aged | Population Surveillance | Cohort Studies | Multiple Sclerosis - drug therapy | Multiple sclerosis | Care and treatment | Development and progression | Interferon | Backup software | Biological response modifiers | Biopharmaceutics | Neurosciences | Immunoglobulins | Laboratories | β-Interferon | Antibodies | Systematic review | Regression analysis | Patients | Consortia | Neurology | Side effects | Demographics | Immunology | Vitamin D | Immunogenicity | Etiology | Collaboration | Biomarkers | Pharmaceuticals | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article
Journal Article
PLoS ONE, ISSN 1932-6203, 2017, Volume 12, Issue 5, p. e0178544
Journal Article
11/2017
The present invention refers to lixisenatide for use in pediatrics. La presente invención se refiere a Iixisenatida para uso en pacientes pediátricos. 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
07/2016
The present invention refers to lixisenatide for use in pediatrics. La présente invention concerne le lixisénatide pour son utilisation en pédiatrie. 
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS | HYGIENE | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | MEDICAL OR VETERINARY SCIENCE | HUMAN NECESSITIES
Patent
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.